NCT07730164

Brief Summary

The goal of this clinical trial is to learn whether a one-page communication aid can improve communication between physicians and patients with cancer during cancer-related truth-telling consultations. The one-page aid is designed to help physicians quickly understand patients' preferences and needs before the consultation. The main questions it aims to answer are:

  • Does the one-page communication aid improve patients' satisfaction with how cancer-related information is explained?
  • Does the one-page communication aid reduce patients' emotional distress after the consultation?
  • Does the one-page communication aid improve physicians' confidence in communicating cancer-related information? Researchers will compare patients whose physicians receive the one-page communication aid with patients whose physicians provide usual care with a blank sheet for patients to write down questions. This comparison will help determine whether the one-page aid improves communication, emotional outcomes, and physician confidence. Participants will:
  • Complete questionnaires before and after the consultation
  • Receive either the one-page communication aid or a blank sheet, depending on their physician's group
  • Complete follow-up questionnaires at 3 months and 6 months after the consultation Physicians will also complete brief questionnaires about their communication confidence at baseline, 1 week after recruitment of their first enrolled patient, 3 months, and 6 months.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
11mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Nov 2025Jul 2027

Study Start

First participant enrolled

November 27, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 21, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 28, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

July 28, 2026

Status Verified

July 1, 2026

Enrollment Period

1.3 years

First QC Date

July 21, 2026

Last Update Submit

July 22, 2026

Conditions

Keywords

Cancer truth-telling; disclosure preferences; physician-patient communication; communication aid; oncology care; psychooncology

Outcome Measures

Primary Outcomes (1)

  • Patients' Truth-Telling Preferences and Perceptions

    Patients' truth-telling preferences and perceptions of physicians' actual disclosure practices will be assessed using the 43-item Truth-Telling Questionnaire (TTQ-43). The TTQ-43 includes four domains: how to deliver bad news, emotional support, additional information, and setting. Items are scored from 1 to 5, with higher scores indicating stronger preferences expectation at baseline or greater perceived alignment with physician practice at follow-up.

    Baseline, immediately after the truth-telling consultation, 3 months post-intervention, and 6 months post-intervention

Secondary Outcomes (8)

  • Patients' Psychological Distress

    Baseline, immediately after the truth-telling consultation, 3 months post-intervention, and 6 months post-intervention

  • Physicians' Confidence in Communication

    Baseline, 1 week after recruitment of the physician's first enrolled patient, 3 months post-intervention, and 6 months post-intervention

  • Patients' Decision Regret

    3 months post-intervention and 6 months post-intervention

  • Treatment-Related Adverse Events

    3 months post-intervention and 6 months post-intervention

  • Medical Expenditure

    6 months post-intervention

  • +3 more secondary outcomes

Study Arms (2)

One-Page Truth-Telling Aid

EXPERIMENTAL

Patients in this arm will receive the One-Page Truth-Telling Aid before the truth-telling consultation. The aid will be completed with the patient before the visit and summarizes the patient's disclosure preferences, communication needs, and questions for the physician. Patients will be encouraged to provide the aid to their participating physician at the beginning of the consultation so that the physician can quickly understand the patient's preferences and tailor communication accordingly.

Behavioral: One-Page Truth-Telling Aid

Blank Sheet

ACTIVE COMPARATOR

Patients in this arm will receive a blank sheet before the truth-telling consultation. The blank sheet may be used to write down questions or concerns the patient would like to discuss with the physician. It does not include structured questions about disclosure preferences or communication needs. Patients will receive usual care and may choose whether to provide the blank sheet to their participating physician during the consultation.

Behavioral: Blank Sheet

Interventions

The One-Page Truth-Telling Aid is a brief communication aid completed with patients before the consultation. It summarizes patients' disclosure preferences, communication needs, and questions for the physician. Patients are encouraged to provide the aid to their participating physician at the beginning of the consultation to support patient-centered communication.

One-Page Truth-Telling Aid
Blank SheetBEHAVIORAL

The blank sheet is provided to patients before the consultation and may be used to write down questions or concerns. It does not include structured questions about disclosure preferences or communication needs.

Blank Sheet

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Physicians who provide clinical care for patients with cancer in participating outpatient departments.
  • Physicians who are involved in cancer-related truth-telling or disclosure consultations.
  • Physicians who are willing to participate and provide informed consent.

You may not qualify if:

  • Physicians who are unable or unwilling to complete study procedures or follow-up assessments.
  • 【Patients】
  • Patients diagnosed with cancer.
  • Patients who are scheduled to receive cancer-related information from a participating physician, including information about diagnosis, recurrence, metastasis, end-of-life status.
  • Patients who are able to communicate in Mandarin Chinese or Taiwanese.
  • Patients who are able to complete questionnaires independently or with assistance from the research assistant.
  • Patients who are willing to participate and provide informed consent.
  • Patients who are unable to provide informed consent.
  • Patients with severe cognitive impairment, severe physical illness, or emotional distress that prevents participation, as judged by the clinical team or research staff.
  • Patients who are unable to complete the study questionnaires even with assistance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung University

Taoyuan, 33302, Taiwan

RECRUITING

MeSH Terms

Conditions

Patient Preference

Condition Hierarchy (Ancestors)

Patient SatisfactionTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Shih-Ying Chen, PhD

    Chang Gung University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Shih-Ying Chen, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patients will be masked to group assignment. Both groups will receive a study sheet before the consultation to support preparation for the visit. Patients in the experimental group will receive the One-Page Truth-Telling Aid, whereas patients in the control group will receive a blank sheet. Physicians and the research assistant cannot be masked because they are involved in delivering information or using the assigned study materials and data collection.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Participating physicians will be assigned to the experimental or control group. Patients will be allocated according to the group assignment of their participating physician. The experimental group will use the One-Page Truth-Telling Aid, whereas the control group will receive usual care with a blank sheet for writing down questions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 21, 2026

First Posted

July 28, 2026

Study Start

November 27, 2025

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

July 28, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because the dataset contains sensitive clinical and communication-related information from patients with cancer and participating physicians. De-identified aggregate results may be reported in publications.

Locations